Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant doses.

Lignende værker

• The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses.
  af: Prise, V, et al.
  Udgivet: (2002)
• Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
  af: Tozer, G, et al.
  Udgivet: (2001)
• Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI.
  af: Maxwell, R, et al.
  Udgivet: (2002)
• Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate.
  af: Lunt, S, et al.
  Udgivet: (2011)
• Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate
  af: Jane Lunt, S, et al.
  Udgivet: (2011)